UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Tilt Investment Management Holdings PBC

Tilt Investment Management Holdings PBC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 22.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,801 shares of the healthcare conglomerate’s stock after selling 1,125 shares during the quarter. UnitedHealth Group accounts for about 2.2% of Tilt Investment Management Holdings PBC’s investment portfolio, making the stock its 7th largest holding. Tilt Investment Management Holdings PBC’s holdings in UnitedHealth Group were worth $2,001,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Axiom Financial Strategies LLC acquired a new stake in UnitedHealth Group in the first quarter valued at approximately $210,000. McGowan Group Asset Management Inc. lifted its stake in UnitedHealth Group by 8.9% during the first quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock worth $379,000 after purchasing an additional 61 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its stake in UnitedHealth Group by 31.8% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock worth $127,592,000 after purchasing an additional 60,300 shares during the last quarter. MAS Advisors LLC lifted its stake in UnitedHealth Group by 10.8% during the first quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock worth $241,000 after purchasing an additional 45 shares during the last quarter. Finally, First Western Trust Bank bought a new position in UnitedHealth Group during the first quarter worth $875,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on UNH shares. Barclays raised their target price on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research note on Wednesday. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Morgan Stanley cut their price objective on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Truist Financial restated a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a research note on Wednesday. Finally, Royal Bank of Canada cut their price objective on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research note on Wednesday. Three equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $569.68.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded up $16.94 during trading hours on Thursday, reaching $495.93. 5,691,234 shares of the company were exchanged, compared to its average volume of 4,480,536. The firm has a market cap of $457.21 billion, a price-to-earnings ratio of 30.39, a PEG ratio of 1.28 and a beta of 0.54. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The stock has a 50-day moving average of $489.51 and a 200 day moving average of $515.38. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s revenue was up 8.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.26 earnings per share. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 27.75 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is presently 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.